- 专利标题： RNA polymerase I inhibitors and uses thereof
-
申请号： US15626198申请日： 2017-06-19
-
公开(公告)号： US10022382B2公开(公告)日： 2018-07-17
- 发明人: Anat Achiron , Roi Mashiach , Michael Gurevich
- 申请人： Tel HaShomer Medical Research Infrastructure and Services Ltd.
- 申请人地址： IL Ramat-Gan
- 专利权人： Tel HaShomer Medical Research Infrastructure and Services Ltd.
- 当前专利权人： Tel HaShomer Medical Research Infrastructure and Services Ltd.
- 当前专利权人地址： IL Ramat-Gan
- 主分类号： A61K31/551
- IPC分类号： A61K31/551 ; C07D471/12 ; C07D513/14
摘要：
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.
公开/授权文献
- US20170290842A1 RNA POLYMERASE I INHIBITORS AND USES THEREOF 公开/授权日：2017-10-12
信息查询
